Skip to main content

Table 1 Baseline characteristics (clinical and demographic)

From: Outcome of highly active antiretroviral therapy in HIV- infected Indian children

Characteristics Values
Age (median, IQR) 119 (75–156) months
Boys 131 (74.9)
Lost one parent 71 (40.5)
Lost both parents 33 (18.9)
Age at diagnosis (median, IQR) 58 (29,96) months
Mode of transmission  
 Perinatal 142 (81.2)
 Blood transfusion 6 (3.4)
 Uncertain 27 (15.4)
WHO clinical stage at diagnosis  
 1 49 (28)
 2 50 (28.6)
 3 56 (32)
 4 20 (11.4)
WHO immune stage at diagnosis, n = 158  
 None 31 (19.6)
 Moderate 12 (7.6)
 Advanced 25 (15.8)
 Severe 90 (57)
WAZ before starting HAART  
 ≥−2 z 136 (77.7)
 < −2 to> −3 14 (8)
 ≤−3 29 (14.3)
HAZ before starting HAART  
 ≥−2 z 148 (84.6)
 < −2 to> −3 9 (5.1)
 ≤−3 18 (10.3)
Received BCG 109 (62.3)
History of contact with TB 60 (34.3 )
TB disease diagnosed before initiating HAART 47 (26.9 )
TB developed after initiating HAART 15 (8.6)
  1. All values are n (%) unless specified. IQR: interquartile range, WHO: World Health Organization, WAZ: weight for age z score, HAZ : height for age z score, BCG: Bacillus Calmette Guerin, HAART: highly active anti-retroviral therapy, TB: tuberculosis.